| Value | ₹1,036 Cr |
|---|
BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,535.00
- Market cap
- ₹42,944 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 40.2×Sector 45.9×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Board Meeting Date
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on 3rd November 2026 to consider and approve its unaudited financial results for the quarter ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GlaxoSmithKline Pharmaceuticals issued a corrigendum for its August 3, 2026, postal ballot notice, correcting a typographical error in a reported salary figure.
GlaxoSmithKline Pharmaceuticals Price Movement Clarification
GlaxoSmithKline Pharmaceuticals clarified that recent trading volume increases are purely market-driven. The company confirmed all material disclosures have been made according to SEBI regulations.
GlaxoSmithKline Pharmaceuticals Business Update
GlaxoSmithKline Pharmaceuticals received an income tax refund intimation of Rs 4.99 Crore for the assessment year 2025-2026.
- Value
- ₹4.99 Cr
Other financial results announcements
All →Medistep Healthcare H1 FY27 Results: Net Profit ₹3.1 Cr, Up 3.3% YoY
Medistep Healthcare Ltd reported revenue from operations of ₹37.4 Cr (+6.6% YoY) and net profit of ₹3.1 Cr (+3.3% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.1 Cr · +3.3% YoY
Lloyds Engineering Works Q2 FY27 Results: Net Profit ₹57.8 Cr, Up 6.2% YoY
Lloyds Engineering Works Ltd reported revenue from operations of ₹593.5 Cr (+87.4% YoY) and net profit of ₹57.8 Cr (+6.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹57.8 Cr · +6.2% YoY
National Aluminium Company Q2 FY27 Results: Net Profit ₹1,835 Cr, Up 28.3% YoY
National Aluminium Company Ltd reported revenue from operations of ₹5,419 Cr (+26.3% YoY) and net profit of ₹1,835 Cr (+28.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,835 Cr · +28.3% YoY
Flair Writing Industries Q2 FY27 Results: Net Profit ₹31.7 Cr, Down 25.8% YoY
Flair Writing Industries Ltd reported revenue from operations of ₹340.1 Cr (+6.0% YoY) and net profit of ₹31.7 Cr (-25.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31.7 Cr · -25.8% YoY
Sadbhav Infrastructure Project Q2 FY27 Results: Net Profit ₹67.9 Cr, Up 168.4% YoY
Sadbhav Infrastructure reported unaudited results for the quarter and half year to September 30, 2026. Auditors qualified the conclusion on recoverability of its RPTPL investment.
- Key figure
- Net profit ₹67.9 Cr · +168.4% YoY
Arvind Port and Infra H1 FY27 Results: Net Profit ₹1.4 Cr, Up 366.7% YoY
Arvind Port and Infra Ltd reported revenue from operations of ₹6.5 Cr (+41.3% YoY) and net profit of ₹1.4 Cr (+366.7% YoY) for H1 FY27.
- Key figure
- Net profit ₹1.4 Cr · +366.7% YoY